Navigation Links
Mylan Declares Quarterly Preferred Stock Dividend
Date:4/16/2009

PITTSBURGH, April 16 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that in accordance with its 2.139 million preferred stock issuance, the company has declared its quarterly dividend of $16.25 per share (based on the annual dividend rate of 6.5% and a liquidation preference of $1,000.00 per share) payable on May 15, 2009, to holders of preferred stock of record as of May 1, 2009.

Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's third largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies.


'/>"/>
SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Mylan Confirms First-to-File Patent Challenge Relating to Xeloda(R) Cancer Treatment
2. Andrew G. Cuneo Joins Mylan as Vice President of Global Business Development
3. Mylan Announces Clarinex(R) Settlement Agreement
4. Mylan Announces Intention to Purchase Remaining Interest in Matrix Laboratories and Delist Matrix from Indian Stock Exchanges
5. Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor
6. Mylans Matrix Receives WHO Approval for First Generic, Heat-Stable Version of HIV Protease Inhibitor
7. Mylan Announces Transition of Chief Financial Officer
8. Mylan Vice Chairman and CEO Robert J. Coury to Ring NASDAQ Stock Market Opening Bell
9. Mylan Schedules Fourth Quarter Financial Results Conference Call and Live Webcast
10. Mylan Receives FDA Approval for First-to-File Generic Depakote(R) ER
11. Mylan Declares Quarterly Preferred Stock Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... 2017 , ... Viewers who like to educate themselves on current issues and ... services, and societal issues tend to appreciate and love the "Informed" series, hosted by ... running events for causes around the world. , Running for charity has ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Finding Christ Through Social ... devotional journal chronicling the writer’s path toward true communion with God. “Finding Christ ... #TruthwithGrace” is the creation of published author Lea Michelle Johnson, a follower of ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Adventures of Joey, The ... silly dog who lives his life to the fullest, as God intended. “The Adventures ... Patti Holmgren, a mother and grandmother pursuing her passion for writing, especially about truth ...
(Date:3/23/2017)... ... March 23, 2017 , ... Demonstrating ... communities, 16 more public health departments have been awarded national accreditation through the ... million people into the expanding network of communities across the nation whose health ...
(Date:3/23/2017)... , ... March 23, 2017 , ... The MBI “Hall of Fame” recognizes the contributions ... have had a significant impact on the careers of all others involved. , ... was inducted into the MBI’s Hall of Fame. The induction took place during the ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , March 24, 2017 ... providing high-quality and cost-effective drug development and ... pharmaceutical and biotechnology industry, announced today the ... ShangPharma will be consolidating the Contract ... (CMO) under Shanghai ChemPartner. These entities include ...
(Date:3/24/2017)... -- A ReportsnReports.com report says, over the recent years, ... global sales of Adcetris and Kadcyla have been witnessing rapid growth ... market is driven by large number of ADC drugs in pipeline, ... by ADCs. ... 3 Tables and 94 Figures, 10 Major Company Profiles, spread across ...
(Date:3/24/2017)... -- Eli Lilly and Company (NYSE: LLY ... in its U.S. operations in 2017. The company,s ... research laboratories, manufacturing sites, and general and administrative ... for Lilly products, as well as its robust ... pain, diabetes and other unmet medical needs.  ...
Breaking Medicine Technology: